Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Tetracyclines: four rings to rule infections through resistance and disease tolerance
Kátia Jesus, Luís F. Moita
Kátia Jesus, Luís F. Moita
Published September 1, 2022
Citation Information: J Clin Invest. 2022;132(17):e162331. https://doi.org/10.1172/JCI162331.
View: Text | PDF
Commentary

Tetracyclines: four rings to rule infections through resistance and disease tolerance

  • Text
  • PDF
Abstract

Several classes of antibiotics have long been known for protective properties that cannot be explained through their direct antimicrobial effects. However, the molecular bases of these beneficial roles have been elusive. In this issue of the JCI, Mottis et al. report that tetracyclines induced disease tolerance against influenza virus infection, expanding their protection potential beyond resistance and disease tolerance against bacterial infections. The authors dissociated tetracycline’s disease-resistance properties from its disease-tolerance properties by identifying potent tetracycline derivatives with minimal antimicrobial activity but increased capacity to induce an adaptive mitochondrial stress response that initiated disease tolerance mechanisms. These findings have potential clinical applications in viral infections.

Authors

Kátia Jesus, Luís F. Moita

×

Figure 1

Tetracycline derivatives with minimal antimicrobial activity have increased capacity to induce an adaptive mitochondrial stress response and enhance disease tolerance.

Options: View larger image (or click on image) Download as PowerPoint
Tetracycline derivatives with minimal antimicrobial activity have increa...
(A) Doxycycline, a prototypical tetracycline antibiotic, blocks bacterial and mitochondrial translation, inducing mild proteotoxic mitochondrial stress, which initiates mitochondrial stress responses. (B) 9-tert-Butyl doxycycline (9-TB), a doxycycline derivative with a substitution at the C9 position, has minimal antimicrobial activity but shows substantially greater capacity to induce the UPRmt and mitochondrial stress response (MSR) when compared with parental doxycycline. (C) Mottis et al. (17) showed that both parental doxycycline and 9-TB improved survival of mice in a model of lethal influenza virus infection, by reducing tissue damage but without affecting viral titers. This finding demonstrates that in addition to the antimicrobial properties of tetracyclines (known as resistance), the effect of this class of antibiotics on the host mitochondria triggers disease tolerance mechanisms in viral infections through activation of MSRs.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts